Due to the lack of commercially available pharmacological therapies indicated to treat muscular dystrophy, the rising prevalence of the condition, and increased research and development for the creation of efficient drugs, North America is predicted to dominate the global market for treating muscular dystrophy. Due to rising public awareness and increased research activity, Europe is anticipated to increase its Muscular Dystrophy Treatment Market share during the forecast period. North America, Latin America, Europe, Asia-Pacific, and the Middle East and Africa make up Coherent Market Insights' regional segmentation of the global market for treating muscular dystrophy. In 2007, 349 out of 2.37 million males aged 5 to 24 were reported to have duchenne muscular dystrophy or becker muscular dystrophy in the United States, according to figures from the Centers for Disease Control and Prevention.
Read more @ https://creativeedge16.blogspot.com/2022/11/muscular-dystrophy-treatment-market.html
